Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Cash & Current Investments (2016 - 2026)

Anika Therapeutics has reported Cash & Current Investments over the past 17 years, most recently at $66.8 million for Q1 2026.

  • Quarterly Cash & Current Investments fell 11.37% to $66.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $66.8 million through Mar 2026, down 11.37% year-over-year, with the annual reading at $81.2 million for FY2025, 2.46% up from the prior year.
  • Cash & Current Investments was $66.8 million for Q1 2026 at Anika Therapeutics, down from $81.2 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $123.6 million in Q2 2022 and troughed at $66.8 million in Q1 2026.
  • The 5-year median for Cash & Current Investments is $96.6 million (2024), against an average of $96.9 million.
  • Year-over-year, Cash & Current Investments surged 34.04% in 2022 and then fell 25.17% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $121.0 million in 2022, then dropped by 21.38% to $95.1 million in 2023, then dropped by 16.7% to $79.2 million in 2024, then grew by 2.46% to $81.2 million in 2025, then dropped by 17.72% to $66.8 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Cash & Current Investments are $66.8 million (Q1 2026), $81.2 million (Q4 2025), and $80.2 million (Q3 2025).